Search

everythinglearnresearchcommunity

for

Search:↓

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Trichoscopy is a useful tool for diagnosing hair and scalp diseases without needing skin biopsies.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

A rare combination of halo nevi, nonsegmental vitiligo, and early gray hair can occur together.

The document concludes that changing the scalp's microbiome might be a new way to treat hair loss.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Dermatopathology has made significant progress but many skin diseases remain incurable, requiring ongoing research.

Hair follicle-derived sheets can effectively treat vitiligo by repigmenting skin.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

Early detection and treatment of acne can prevent scarring and improve quality of life.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

High TNF-α levels may increase hair loss risk after PRP therapy.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Microneedling may improve melasma treatment by boosting topical therapy effectiveness.

Fluralaner effectively cures canine demodicosis in 28 days.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.